Cargando…
Myasthenic crisis in the setting of Coronavirus Disease 2019 (COVID-19)
• A patient with Myasthenia Gravis (MG) on immunosuppressive therapy with underlying respiratory compromise may be more susceptible to infection with COVID-19 or severe manifestations of the virus. • It is theorized that patients with MG may be more vulnerable to bacterial and viral infections, due...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368911/ https://www.ncbi.nlm.nih.gov/pubmed/32707518 http://dx.doi.org/10.1016/j.jclinane.2020.110001 |